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Antimicrobial Peptides (AMPs)
Abstract: Antimicrobial peptides are short peptides recently discovered that belong to the first line of defense against invading pathogens. They have 
been described from bacteria, insects, plants and vertebrates, and are classified in several groups depending on their structure. Several mechanism of action 
have been proposed to explain the interaction with bacterial membranes, but in general, they cause lytic pores. In most of the cases, these peptides are 
ribosomally sintethized, some of them as pre-proteins. Several applications have been proposed to control bacterial infections, especially skin infections or in 
the mucosal areas.
AMPs show different ways to interfere 
in cell viability. 
1) Interfering in metabolic pathways or 
dna synthesis.
2) Producing pores that kill cells by lisis.
Once the critical peptide concentration 
is reached in membrane the peptides 
interact to create a pore .
AMPs can be found in many different 
species, most of them came from 
vertebrate animals but there are a lot of 
AMP produced by plants, 
microorganisms, insects, marine 
invertebrates and others.
Nowadays Scientifics are studying AMPs 
from different species to use them as 
therapy against a wide spectrum of 
diseases.
AMPs can be classified in four grups: 
alfa-helix, cisteine rich peptides, betta
sheet, high aminoacid content. Some
peptides can have modified aminoacids
in their structure, like D-aminoacids.
• Antibacterial Peptides
• Antiviral Peptides (Anti-HIV Peptides) 
• Antifungal Peptides
• Antiparasitic Peptides (Antimalarial) 
• Anticancer Peptides
• Anti-protist Peptides
• Insecticidal Peptides
• Spermicidal Peptides
• Chemotactic peptides
• Antioxidant peptides
• Protease inhibitors
Two types of resistance are described: 
intrinsic resistance or constitutive, and 
adaptive resistance or inducible. In the 
first the factors involved are always 
present, in contrast to the inducible 
activation occurs microbial factors 
needed to survive in sub-lethal levels of 
AMPs.
PAMs are synthesized as large precursors 
that contain one or more copies of the 
active segment cleaved via  proteolythic
processing. The release of the N-
terminal signal peptide leaves free the 
active part, but generally one or more 
anionic segments are removed during 
the process. There are two expression 
patterns: 1) Constitutive
2) Induced expression by TLRs
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Other functions
·histamine secretion
·IL 8 secretion
·T cell proliferation
·Angiogenesis
Applications
Production
alternative
• Short peptides
• No postraductional
modifications
• Low yields
• High costs
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Limitations
how can we solve this?
AMPs can be applied to many 
different types of industries as: 
pharma, veterinary, plants, food, 
biomaterials, biocides, cosmetics,  
or antimicrobial materials. The 
peptides used in each industry are 
going to be different, so it might be 
a good idea to find a standard 
system to produce them for future 
applications. 
Melittin is a toxic peptide 
that is present in the venom 
of bees. Scientists have 
already used it to attack 
cancer cells, taking advantage 
of their potential to create 
holes in cell membranes. In 
Washington university, 
nanoparticles loaded with 
melittin were used to attack 
the viral envelope VIH.[1]
Nowadays AMPs are mainly 
produced via chemical synthesis, or 
microbial fermentation. These two 
methods present some limitations
like: peptides without post-
translational modifications, length  
limitations, toxicity, low yields and 
expensive costs. 
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Figure 1: AMP distribution Figure 2: AMP  examples
Figure 3: pore formation via AMP Figure 4: AMP functions
Figure 5: AMP generation via TLR Figure 6: resistance mechanisms
• Surface charges alteration
• Alterations in  lipid A,
• Membrane protein changes
• Proteolithyc enzimes
• Membrane fluency reduction
• PAM neutralitzation
• Membrane transporters
